JP7785682B2 - ソフトゲルカプセル - Google Patents

ソフトゲルカプセル

Info

Publication number
JP7785682B2
JP7785682B2 JP2022555945A JP2022555945A JP7785682B2 JP 7785682 B2 JP7785682 B2 JP 7785682B2 JP 2022555945 A JP2022555945 A JP 2022555945A JP 2022555945 A JP2022555945 A JP 2022555945A JP 7785682 B2 JP7785682 B2 JP 7785682B2
Authority
JP
Japan
Prior art keywords
acid
gelatin
softgel capsule
shell composition
softgel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022555945A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023518245A (ja
JPWO2021188773A5 (https=
JP2023518245A5 (https=
Inventor
シェリー，リッキー，スティーブ
Original Assignee
アール．ピー．シェーラー テクノロジーズ，エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アール．ピー．シェーラー テクノロジーズ，エルエルシー filed Critical アール．ピー．シェーラー テクノロジーズ，エルエルシー
Publication of JP2023518245A publication Critical patent/JP2023518245A/ja
Publication of JPWO2021188773A5 publication Critical patent/JPWO2021188773A5/ja
Publication of JP2023518245A5 publication Critical patent/JP2023518245A5/ja
Priority to JP2025225446A priority Critical patent/JP2026035788A/ja
Application granted granted Critical
Publication of JP7785682B2 publication Critical patent/JP7785682B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
JP2022555945A 2020-03-18 2021-03-18 ソフトゲルカプセル Active JP7785682B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025225446A JP2026035788A (ja) 2020-03-18 2025-12-03 ソフトゲルカプセル

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062991354P 2020-03-18 2020-03-18
US62/991,354 2020-03-18
PCT/US2021/022918 WO2021188773A1 (en) 2020-03-18 2021-03-18 Softgel capsules

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025225446A Division JP2026035788A (ja) 2020-03-18 2025-12-03 ソフトゲルカプセル

Publications (4)

Publication Number Publication Date
JP2023518245A JP2023518245A (ja) 2023-04-28
JPWO2021188773A5 JPWO2021188773A5 (https=) 2024-03-21
JP2023518245A5 JP2023518245A5 (https=) 2024-03-21
JP7785682B2 true JP7785682B2 (ja) 2025-12-15

Family

ID=77771391

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022555945A Active JP7785682B2 (ja) 2020-03-18 2021-03-18 ソフトゲルカプセル
JP2025225446A Pending JP2026035788A (ja) 2020-03-18 2025-12-03 ソフトゲルカプセル

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025225446A Pending JP2026035788A (ja) 2020-03-18 2025-12-03 ソフトゲルカプセル

Country Status (11)

Country Link
US (1) US20230172864A1 (https=)
EP (1) EP4121036A4 (https=)
JP (2) JP7785682B2 (https=)
KR (1) KR20220154196A (https=)
AR (1) AR121608A1 (https=)
AU (1) AU2021238345A1 (https=)
BR (1) BR112022018268A2 (https=)
CA (1) CA3171512A1 (https=)
CO (1) CO2022014130A2 (https=)
MX (1) MX2022011549A (https=)
WO (1) WO2021188773A1 (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150366814A1 (en) 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
JP2018514511A (ja) 2015-04-14 2018-06-07 アトッサ ジェネティックス インク． 乳房障害とエストロゲン関連障害の処置のための組成物と方法
WO2019174990A1 (en) 2018-03-15 2019-09-19 Altergon S.A. Highly stable formulations of thyroid hormone in soft capsules

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133939A1 (en) * 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
EP1545477A4 (en) * 2002-09-13 2006-11-22 Cydex Inc CAPSULES CONTAINING AQUEOUS FILLING COMPOSITIONS STABILIZED WITH DERIVED CYCLODEXTRIN
ITMI20022777A1 (it) * 2002-12-27 2004-06-28 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
EP2444071A1 (en) * 2004-09-27 2012-04-25 Sigmoid Pharma Limited Minicapsule formulations
CN1872061A (zh) * 2006-04-17 2006-12-06 宛六一 一种药物组合物软胶囊及其制备方法
JP5840668B2 (ja) * 2012-12-07 2016-01-06 富士カプセル株式会社 ロキソプロフェンナトリウム含有軟カプセル用内容物、及び、それを含有する軟カプセル製剤
US10420729B2 (en) * 2013-03-15 2019-09-24 R.P. Scherer Technologies, Llc Abuse resistant capsule
US9326947B1 (en) * 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
US9775814B2 (en) * 2014-06-20 2017-10-03 Patheon Softgels Inc. Enteric soft capsule compositions
ES2787220T3 (es) * 2015-03-26 2020-10-15 Patheon Softgels Inc Cápsulas blandas llenas de líquido
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
IL316439A (en) * 2018-03-15 2024-12-01 Scherer Technologies Llc R P Enteric softgel capsules

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150366814A1 (en) 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
JP2018514511A (ja) 2015-04-14 2018-06-07 アトッサ ジェネティックス インク． 乳房障害とエストロゲン関連障害の処置のための組成物と方法
WO2019174990A1 (en) 2018-03-15 2019-09-19 Altergon S.A. Highly stable formulations of thyroid hormone in soft capsules

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
医薬品製造用 アクリルポリマー Eudragit(R) オイドラギット（Ｒ）

Also Published As

Publication number Publication date
EP4121036A4 (en) 2024-04-10
CO2022014130A2 (es) 2022-10-31
US20230172864A1 (en) 2023-06-08
EP4121036A1 (en) 2023-01-25
JP2023518245A (ja) 2023-04-28
MX2022011549A (es) 2022-10-13
JP2026035788A (ja) 2026-03-04
KR20220154196A (ko) 2022-11-21
BR112022018268A2 (pt) 2022-10-25
AU2021238345A1 (en) 2022-10-06
AR121608A1 (es) 2022-06-22
WO2021188773A1 (en) 2021-09-23
CA3171512A1 (en) 2022-09-23

Similar Documents

Publication Publication Date Title
JP7558204B2 (ja) 遅延放出ソフトゲルカプセル
JP7628537B2 (ja) より高いｐｈ環境における遅延放出ソフトゲルカプセル
JP7303221B2 (ja) 腸溶性ソフトゲルカプセル剤
KR20230106641A (ko) 지연 방출 소프트겔 캡슐
JP7443266B2 (ja) 腸溶性ソフトゲルカプセル剤
KR20230106642A (ko) 지연 방출 소프트겔 캡슐
KR20230018445A (ko) 지연 방출 소프트겔 캡슐
JP7785682B2 (ja) ソフトゲルカプセル
RU2828673C1 (ru) КАПСУЛЫ ЗАДЕРЖАННОГО ВЫСВОБОЖДЕНИЯ ИЗ МЯГКОГО ЖЕЛАТИНА В СРЕДЕ С БОЛЕЕ ВЫСОКИМ ЗНАЧЕНИЕМ pH
RU2844033C1 (ru) Капсулы задержанного высвобождения из мягкого желатина
TWI920029B (zh) 緩釋軟膠囊
RU2822392C2 (ru) Капсулы задержанного высвобождения из мягкого желатина
RU2789789C2 (ru) Энтеросолюбильные капсулы из мягкого желатина
JP2026500927A (ja) ソフトゲルカプセル及びソフトゲルカプセルを調製するための方法
JP2025527319A (ja) コーティングされた腸溶性ソフトゲルカプセル剤
HK40037171B (zh) 肠溶性软明胶胶囊

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240311

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240311

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20241129

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250221

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250520

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250709

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20251104

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20251203

R150 Certificate of patent or registration of utility model

Ref document number: 7785682

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150